Allegro Ophthalmics Announces Last Patient Enrolled in PACIFIC Phase 2b Clinical Trial of Luminate® for Non-Proliferative Diabetic Retinopathy

SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--Allegro Ophthalmics completed enrollment in its PACIFIC Phase 2b clinical trial evaluating the safety and efficacy of Luminate® in inducing PVD in patients with non-proliferative diabetic retinopathy.